| __timestamp | Bausch Health Companies Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 17992000000 |
| Thursday, January 1, 2015 | 2682700000 | 22400000000 |
| Friday, January 1, 2016 | 2810000000 | 23910000000 |
| Sunday, January 1, 2017 | 2582000000 | 23813000000 |
| Monday, January 1, 2018 | 2473000000 | 24694000000 |
| Tuesday, January 1, 2019 | 2554000000 | 23557000000 |
| Wednesday, January 1, 2020 | 2367000000 | 25436000000 |
| Friday, January 1, 2021 | 2624000000 | 24586000000 |
| Saturday, January 1, 2022 | 2625000000 | 27295000000 |
| Sunday, January 1, 2023 | 2917000000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Data in motion
In the ever-evolving landscape of the healthcare industry, understanding the financial dynamics of major players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Walgreens Boots Alliance, Inc. and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Walgreens consistently outpaced Bausch in SG&A spending, with an average annual expense nearly ten times higher. Notably, Walgreens' SG&A expenses peaked in 2024, reflecting a strategic expansion or increased operational costs. In contrast, Bausch Health showed a steady trend with a slight uptick in 2023, indicating a potential shift in their operational strategy. The data highlights the contrasting financial strategies of these two giants, offering insights into their market positioning and operational priorities. Missing data for Bausch in 2024 suggests a need for further investigation into their financial reporting.
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Merus N.V.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.